Process for manufacturing glatiramer acetate product
AssigneeTeva Pharmaceutical Industries Ltd.
InventorsRakefet Cohen, Sasson Habbah, Muhammad Safadi
Life of this patent
Estimating the term…
Loading patent…
AssigneeTeva Pharmaceutical Industries Ltd.
InventorsRakefet Cohen, Sasson Habbah, Muhammad Safadi
Estimating the term…
The patent provides a process of preparing a pharmaceutical preparation of glatiramer acetate and mannitol in a suitable container comprising the steps of: (i) obtaining an aqueous pharmaceutical solution of glatiramer acetate and mannitol; (ii) filtering the aqueous pharmaceutical solution at a temperature of from above 0° C. up to 17.5° C. to produce a filtrate; and (iii) filling the suitable container with the filtrate obtained after performing step (ii), so as to thereby prepare the pharmaceutical preparation of glatiramer acetate and mannitol in the suitable container. This patent further provides an aqueous pharmaceutical solution comprising 40 mg/ml glatiramer acetate and 40 mg/ml mannitol, wherein the aqueous pharmaceutical solution a) has a viscosity in the range of 2.0-3.5 cPa; or b) has an osmolality in the range of 275-325 mosmol/Kg. This patent also provides a prefilled syringe, an automated injector and a method of treatment of a human patient.
A process of preparing a pharmaceutical preparation of glatiramer acetate and mannitol in a suitable container comprising the steps of:
The process of any one of claims 2-14, wherein the aqueous pharmaceutical solution is passed through the second filter at a rate of 3-25 liters/hour;
An aqueous pharmaceutical solution comprising 40 mg/ml glatiramer acetate and 40 mg/ml mannitol, wherein the aqueous pharmaceutical solution
Dependencies are inferred from the claim text.